| 000 | 01415 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513201704.0 | ||
| 264 | 0 | _c20000216 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/(sici)1097-0142(20000115)88:2<375::aid-cncr19>3.0.co;2-m _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, D K | |
| 245 | 0 | 0 |
_aA phase II trial of high dose epirubicin in patients with advanced breast carcinoma. _h[electronic resource] |
| 260 |
_bCancer _cJan 2000 |
||
| 300 |
_a375-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aEpirubicin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVentricular Function, Left _xdrug effects |
| 700 | 1 | _aMunshi, N | |
| 700 | 1 | _aLoesch, D | |
| 700 | 1 | _aEinhorn, L E | |
| 700 | 1 | _aSledge, G W | |
| 773 | 0 |
_tCancer _gvol. 88 _gno. 2 _gp. 375-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1097-0142(20000115)88:2<375::aid-cncr19>3.0.co;2-m _zAvailable from publisher's website |
| 999 |
_c10596240 _d10596240 |
||